new antibiotics established under the Generating New Antibiotic Incentives Now (GAIN) Act. In 2019, FDA granted "Fast Track" designation to ibezapolstat for the treatment of patients with CDI. The CDC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback